πŸ‡ΊπŸ‡Έ FDA
Patent

US 9963443

Radiolabeled compounds

granted A61KA61K51/0455A61K51/0459

Quick answer

US patent 9963443 (Radiolabeled compounds) held by Takeda Pharmaceutical Company Limited expires Mon May 03 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue May 08 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 03 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K51/0455, A61K51/0459, A61P, A61P25/00